The Effects of Daridorexant 50 mg on Patients with Comorbid Insomnia Disorder and Untreated Mild OSA: A Subgroup Post-hoc Analysis of a Phase 3 Clinical Trial

If you would like to request any additional information, please contact Idorsia Medical Information by completing the medical inquiry form found  here.